Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer

[1] Sauer R(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[2] Liersch T(2000)Preoperative radiotherapy for resectable rectal cancer: a meta-analysis JAMA 284 1008-1015

[3] Merkel S(2007)The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 693-701

[4] Cammà C(1998)Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997 Arch Surg 133 894-899

[5] Giunta M(2011)Patterns of local recurrence in rectal cancer after a multidisciplinary approach World J Gastroenterol 17 1674-1684

[6] Fiorica F(2001)Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and Para-aortic irradiation Int J Radiat Oncol Biol Phys 51 261-266

[7] Pagliaro L(2008)Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer Int J Radiat Oncol Biol Phys 71 1504-1510

[8] Craxì A(2018)Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity Jpn J Clin Oncol 48 458-466

[9] Cottone M(2017)Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529 Adv Radiat Oncol 2 110-117

[10] Peeters KCMJ(2014)Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy Radiother Oncol 113 29-34

[1] Sauer R(2012)Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years J Clin Oncol 30 1926-1933

[2] Liersch T(2000)Preoperative radiotherapy for resectable rectal cancer: a meta-analysis JAMA 284 1008-1015

[3] Merkel S(2007)The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 693-701

[4] Cammà C(1998)Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997 Arch Surg 133 894-899

[5] Giunta M(2011)Patterns of local recurrence in rectal cancer after a multidisciplinary approach World J Gastroenterol 17 1674-1684

[6] Fiorica F(2001)Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and Para-aortic irradiation Int J Radiat Oncol Biol Phys 51 261-266

[7] Pagliaro L(2008)Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer Int J Radiat Oncol Biol Phys 71 1504-1510

[8] Craxì A(2018)Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity Jpn J Clin Oncol 48 458-466

[9] Cottone M(2017)Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529 Adv Radiat Oncol 2 110-117

[10] Peeters KCMJ(2014)Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy Radiother Oncol 113 29-34